Repligen replacing Hi-Tech Pharmacal in S&P 600


Repligen (RGEN) will take Hi-Tech Pharmacal's (HITK) spot in the S&P SmallCap 600 following Thursday's close.

RGEN +2.6% AH

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs